Atlantic Edge Private Wealth Management LLC lowered its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 26.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 400 shares of the company’s stock after selling 141 shares during the quarter. Atlantic Edge Private Wealth Management LLC’s holdings in Colgate-Palmolive were worth $36,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently modified their holdings of the company. Union Bancaire Privee UBP SA purchased a new stake in Colgate-Palmolive in the 4th quarter worth $32,000. Hager Investment Management Services LLC bought a new position in Colgate-Palmolive in the 4th quarter worth about $36,000. Reston Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive in the 3rd quarter worth approximately $42,000. Capital Performance Advisors LLP purchased a new stake in Colgate-Palmolive during the third quarter valued at approximately $53,000. Finally, Synergy Asset Management LLC purchased a new stake in Colgate-Palmolive during the fourth quarter valued at approximately $49,000. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Stock Performance
CL stock opened at $85.94 on Tuesday. Colgate-Palmolive has a 1 year low of $82.68 and a 1 year high of $109.30. The stock’s fifty day moving average is $90.36 and its two-hundred day moving average is $96.77. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41. The stock has a market capitalization of $70.21 billion, a price-to-earnings ratio of 24.41, a PEG ratio of 4.12 and a beta of 0.44.
Colgate-Palmolive Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.33%. Colgate-Palmolive’s dividend payout ratio is 56.82%.
Analysts Set New Price Targets
A number of research analysts have issued reports on the stock. Barclays decreased their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. TD Cowen dropped their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Raymond James reiterated an “outperform” rating and set a $105.00 price target (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. Finally, UBS Group lowered their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a report on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $101.16.
View Our Latest Stock Analysis on Colgate-Palmolive
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- NYSE Stocks Give Investors a Variety of Quality Options
- Monday.com Stock Could Soar to New Highs—Here’s How
- 3 Tickers Leading a Meme Stock Revival
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Stock Analyst Ratings and Canadian Analyst Ratings
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.